Pacesetter will support researchers in exploring market potential for new rehabtech concepts and developing understanding around routes to market via new spin-out companies or licencing to other organisations. This opportunity has been designed to complement our other funding mechanisms as well as existing regional and national accelerator programmes.
EMERGE RehabTech aims to accelerate translation of novel rehabtech, deliver economic impact and drive development and deployment of devices, services and tools that benefit people in the East Midlands. Through Pacesetter, we aim to empower researchers to test commercial potential and establish end-user need, providing confidence around the appropriate route to market. A combination of focussed training, mentoring and tailored funding will support researchers to determine demand for their rehabtech from a sustainable customer base and tackle questions around routes to deployment.
Pacesetter is a three-stage, intensive programme funded by EMERGE RehabTech and delivered with support from EMERGE consortium members. Participants that progress successfully to Phase 3 will be eligible to request funding to access support for in-depth market evaluation.
The programme will be open to academics, researchers and clinicians working at eligible organisations within the EMERGE RehabTech consortium.